FARXIGA dapagliflozin

Who Makes FARXIGA (dapagliflozin)?

FARXIGA is manufactured by AstraZeneca, a British multinational pharmaceutical and biotechnology company headquartered at the Cambridge Biomedical Campus in Cambridge, England. FARXIGA is the brand name for the medication dapagliflozin.

FARXIGA Manufacturer Overview

Active IngredientDapagliflozin
FDA-Approval DateJanuary 8, 2014
FDA-Approved UsesType 2 diabetes
Chronic kidney disease
Heart failure

What Does FARXIGA Treat?

FARXIGA is primarily used to treat type 2 diabetes by helping to control blood sugar levels. It works by blocking the reabsorption of glucose by the kidneys, leading to its excretion in the urine.

Additionally, FARXIGA has been approved for other health conditions, including:

  • Chronic kidney disease: FARXIGA lowers the risk of further worsening of kidney disease, end-stage kidney disease, death due to cardiovascular disease, and hospitalization for heart failure in adults with chronic kidney disease at risk of progression
  • Heart failure: FARXIGA reduces the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits in adults with heart failure.

It’s important to remember that FARXIGA is a prescription medication and should only be taken under the supervision of a healthcare professional. They can determine if FARXIGA is the right treatment for your specific condition and address any potential risks or side effects.

Explore More Medication Manufacturers

Now that you know more about who makes FARXIGA, the manufacturer details, and what medical conditions it treats, you may want to compare FARXIGA to other medication manufacturers.

Browse the medication maker guides to research popular brands and find information on a specific company.

Similar Posts